• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一例接受依托泊苷、阿霉素、顺铂和米托坦联合治疗后缓解的转移性肾上腺皮质癌患者的病例报告]

[A Case Report of a Patient with Metastatic Adrenocortical Carcinoma who Received the Combination Etoposide, Doxorubicin, Cisplatin, and Mitotane Therapy and Achieved Remission].

作者信息

Ueda Shota, Nakane Keita, Namiki Sanae, Takeuchi Yasumichi, Kawase Makoto, Takeuchi Shinichi, Kawase Kota, Nakai Chie, Kato Daiki, Takai Manabu, Iinuma Koji, Tsuchiya Tomohiro, Miyazaki Tatsuhiko, Koie Takuya

机构信息

The Department of Urology, Gifu University Graduate School of Medicine.

The Department of Pathology, Gifu University School of Medicine.

出版信息

Hinyokika Kiyo. 2022 May;68(5):139-143. doi: 10.14989/ActaUrolJap_68_5_139.

DOI:10.14989/ActaUrolJap_68_5_139
PMID:35748231
Abstract

A 40-year-old Japanese female was referred to our institution with a high serum lactate dehydrogenase level. Computed tomography (CT) showed a large right adrenal tumor, 14 cm in size without distant metastases. The patient was clinically diagnosed with T2N0M0 adrenocortical carcinoma and underwent right adrenalectomy. The pathological diagnosis was adrenocortical carcinoma with negative surgical margin. The patient was administered mitotane for 2 years as adjuvant therapy. Subsequently, CT revealed asynchronous multiple metastases, including liver, lung, left kidney, and right acetabulum. The patient received 15 courses of EDP (a combination of etoposide, doxorubicin, and cisplatin) plus mitotane therapy, and had stable disease without new lesions.

摘要

一名40岁的日本女性因血清乳酸脱氢酶水平升高被转诊至我院。计算机断层扫描(CT)显示右侧肾上腺有一个大肿瘤,大小为14厘米,无远处转移。该患者临床诊断为T2N0M0肾上腺皮质癌,并接受了右侧肾上腺切除术。病理诊断为肾上腺皮质癌,手术切缘阴性。患者接受了2年的米托坦辅助治疗。随后,CT显示出现包括肝脏、肺、左肾和右髋臼在内的异时性多发转移。该患者接受了15个疗程的EDP(依托泊苷、阿霉素和顺铂联合)加米托坦治疗,病情稳定,无新病灶。

相似文献

1
[A Case Report of a Patient with Metastatic Adrenocortical Carcinoma who Received the Combination Etoposide, Doxorubicin, Cisplatin, and Mitotane Therapy and Achieved Remission].[一例接受依托泊苷、阿霉素、顺铂和米托坦联合治疗后缓解的转移性肾上腺皮质癌患者的病例报告]
Hinyokika Kiyo. 2022 May;68(5):139-143. doi: 10.14989/ActaUrolJap_68_5_139.
2
Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.米托坦联合依托泊苷、阿霉素和顺铂治疗晚期肾上腺皮质癌。意大利肾上腺癌研究小组。
Cancer. 1998 Nov 15;83(10):2194-200.
3
[A Case of Adrenocortical Carcinoma Successfully Treated with Multimodal Therapy].[一例肾上腺皮质癌经多模式治疗成功治愈的病例]
Hinyokika Kiyo. 2016 Jan;62(1):15-9.
4
[Three Cases of Advanced or Recurrent Adrenocortical Carcinoma Patients Treated with Etoposide, Doxorubicin and Cisplatin plus Mitotane].依托泊苷、阿霉素、顺铂联合米托坦治疗晚期或复发性肾上腺皮质癌三例报告
Gan To Kagaku Ryoho. 2018 Jan;45(1):67-70.
5
Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.米托坦与顺铂、依托泊苷和阿霉素联合用于晚期儿童肾上腺皮质癌:米托坦监测与肿瘤消退
J Pediatr Hematol Oncol. 2006 Aug;28(8):513-24. doi: 10.1097/01.mph.0000212965.52759.1c.
6
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.转移性肾上腺皮质癌联合化疗与手术切除的II期试验:持续输注阿霉素、长春新碱和依托泊苷,每日服用米托坦作为P-糖蛋白拮抗剂。
Cancer. 2002 May 1;94(9):2333-43. doi: 10.1002/cncr.10487.
7
[A Case of Aldosterone-Producing Adrenocortical Carcinoma].[一例分泌醛固酮的肾上腺皮质癌]
Hinyokika Kiyo. 2023 May;69(5):131-135. doi: 10.14989/ActaUrolJap_69_5_131.
8
Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1-3 Adrenocortical Cancer After Surgery.米托坦联合或不联合顺铂和依托泊苷用于1-3期肾上腺皮质癌术后复发高危患者。
Ann Surg Oncol. 2023 Feb;30(2):680-682. doi: 10.1245/s10434-022-12725-4. Epub 2022 Oct 28.
9
Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study.EDP-M 对转移性肾上腺皮质癌患者生存的影响:一项基于人群的研究。
Eur J Cancer. 2024 Jan;196:113424. doi: 10.1016/j.ejca.2023.113424. Epub 2023 Nov 10.
10
Adrenocortical Carcinoma: Role of Adjuvant and Neoadjuvant Therapy.肾上腺皮质癌:辅助和新辅助治疗的作用。
Surg Oncol Clin N Am. 2023 Apr;32(2):279-287. doi: 10.1016/j.soc.2022.10.005.